Time spent with residual viremia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

Up to 77% of patients with HIV infection have residual viremia (RV) below 50 copies/mL during antiretroviral therapy (ART) [1]. Although both the source and the full clinical implications of this finding are currently matter of debate, RV has been associated with a higher risk of subsequent virological failure (VF) in several observational studies [2 –6].
Source: International Journal of Antimicrobial Agents - Category: Drugs & Pharmacology Authors: Source Type: research